Disclosure Panels Details Page
Neuroendocrine Tumors Panel - Disclosures as of 09/18/2017
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Al Benson III MD, FACCC, FACP, FASCO | Advanced Accelerator Applications SA Alchemia Limited Astellas Pharma US, Inc. AVEO Pharmaceuticals, Inc. Bayer HealthCare EMD Serono Genentech, Inc. Gilead Infinity Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Boehringer Ingelheim GmbH Bristol Myers Squibb Celgene Corporation Eli Lilly and Company EMD Serono Exelixis Inc. Genentech, Inc. Genomic Health, Inc. ImClone Systems Incorporated Merck & Co., Inc. National Cancer Institute Oncosil Medical sanofi-aventis U.S. Spectrum Pharmaceutics Taiho Pharmaceuticals Co., Ltd. |
None | None | ✔ |
| Emily Bergsland MD | Lexicon Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Exelixis Inc. ipsen lexicon, Inc MOREHealth |
None | None | ✔ |
| Jordan Berlin MD | AbbVie, Inc. Bayer HealthCare emd serono fiveprime immunomedics Incyte Loxo National Cancer Institute OncoMed Pharmaceuticals psioxus symphogen Taiho Pharmaceuticals Co., Ltd. |
BeiGene Celgene Corporation EMD serono Erytech Exelixis Inc. Fiveprime Genentech, Inc. gritstone karyopharm rafael symphogen Vertex Pharmaceuticals Incorporated |
None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Lawrence Blaszkowsky MD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Jennifer Eads MD | AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol Myers Squibb Calithera Pharmaceuticals Celgene Corporation Leap Therapeutics Merck & Co., Inc. Novartis Pharmaceuticals Corporation Verastem |
Amgen Inc. Merrimack |
None | None | ✔ |
| Lyska Emerson MD | None | None | None | None | - |
| Paul Engstrom MD, FACP | None | None | None | None | - |
| Paul Fanta MD | None | None | None | None | ✔ |
| Thomas Giordano MD, PhD | None | Various Law Firms | None | None | ✔ |
| Whitney Goldner MD | AstraZeneca Pharmaceuticals LP Eisai Inc. Roche Laboratories, Inc. |
None | None | None | ✔ |
| John Grecula MD | Soligenix Teva Pharmaceuticals |
None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Thorvardur Halfdanarson MD | Boston Biomedical Esanex Ipsen |
Ipsen Lexicon Merrimack |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jin He MD, PhD | None | None | None | None | ✔ |
| Martin Heslin MD | None | BestDoctors | None | None | - |
| Gregory Kalemkerian MD | GSK Merck & Co., Inc. OncoMed Pharmaceuticals Takeda Pharmaceuticals North America, Inc. |
None | None | None | - |
| Fouad Kandeel MD, PhD | None | None | None | None | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Wajih Zaheer Kidwai MD | None | None | None | None | ✔ |
| Matthew Kulke MD, MMSc | None | Ipsen Lexicon Pharmaceuticals Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Pamela Kunz MD | Advanced Acccelerator Applications Dicerna Esanex Genentech, Inc. Incyte Ipsen Lexicon Pharmaceuticals Merck & Co., Inc. Oxigene |
Ipsen Lexicon |
None | None | ✔ |
| Boris Kuvshinoff MD, MBA | None | None | None | None | ✔ |
| Christopher Lieu MD | Immune Design | Merck & Co., Inc. | None | None | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Robert Merritt MD | None | None | None | None | - |
| Jeffrey Moley MD | AstraZeneca Pharmaceuticals LP Exelixis Inc. |
Exelixis Inc. | None | None | - |
| Ndiya Ogba PhD | None | None | None | None | ✔ |
| Venu Pillarisetty MD | Merck & Co., Inc. | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Leonard Saltz MD | Taiho Pharmaceuticals Co., Ltd. | None | None | None | ✔ |
| Manisha Shah MD | Eisai Inc. Merck & Co., Inc. |
Eisai Inc. Loxo |
None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Julie Ann Sosa MD | AstraZeneca Pharmaceuticals LP Eli Lilly and Company GSK NovoNordisk |
None | None | None | ✔ |
| Jonathan Strosberg MD | Novartis Pharmaceuticals Corporation Pharmacyclics |
Novartis Pharmaceuticals Corporation | Ipsen Lexicon |
None | ✔ |
| Craig Sussman MD | None | None | None | None | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Nataliya Uboha MD, PhD | None | None | None | None | ✔ |
| Amanda Visnick BSN, RN, OCN | None | None | None | None | - |
| James Yao MD | AAA National Cancer Institute Novartis Pharmaceuticals Corporation |
Ipsen Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
None | None | ✔ |